Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

OHRP $3.25 0.3000 +10.17%
CELG $104.72 6.3100 +6.41%
BMY $51.96 2.6700 +5.42%
XLRN $28.00 1.0800 +4.01%
UTHR $116.34 3.2600 +2.88%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

AGEN $4.33 -0.9000 -17.21%
SCLN $9.05 -0.8000 -8.12%
KPTI $7.84 -0.5100 -6.11%
IDRA $1.71 -0.1100 -6.04%
BCRX $4.31 -0.2700 -5.90%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Finding the Way to Lung Tumours by “GPS”

(SINTEF [Oslo, Norway]) June 18, 2013 - The innumerable divisions of the bronchi often turn the hunt for tumours in the lungs into a game of chance. But soon, lung specialists will be able to navigate accurately inside the airways by “GPS”.
read press release 

Financial Engineering Could Heal Medical Funding Ills

(Financial Times) June 16, 2013 - The cancer-fighting ‘super fund’ idea deserves to be given a chance.
read article 

Call for Overhaul of Drug Industry Business Model

(Reuters) June 19, 2013 - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
read article 

Genmab, ADC Using Warheads to Make New Antibody-Drug Conjugate

(GEN News) June 17, 2013 - Genmab and ADC Therapeutics will be developing a new antibody-drug conjugate (ADC) product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.
read article 

New Ambrx CEO Discusses Latest Deal, with China’s Zhejiang Medicine

(Xconomy San Diego) June 18, 2013 - San Diego’s Ambrx, co-founded in 2003 by the prominent chemist Peter Schultz (who remains on its board), has advanced its technology for antibody-drug conjugates by forging a series of drug discovery and development partnerships with Big Pharmas like Merck, Eli Lilly, Astellas, and Bristol-Myers Squibb.
read article 

Check Please: Choosing the Best Hospital for Your Cancer Surgery

(CURE Magazine) June 17, 2013 - While many healthcare professionals benefit from insider knowledge of high-quality facilities and providers, patients facing cancer surgery have relatively few resources beyond marketing materials and their doctor’s recommendation.
read article 

OnCure Holdings, Cancer Clinic Operator, Files Bankruptcy

(Bloomberg) June 17, 2013 - OnCure Holdings Inc., which provides equipment and management services to cancer clinics in three states, filed for bankruptcy blaming cuts in federal health-insurance payments.
read article 

Intuitive Surgical Touted as “One of Few” Growth Stocks in Med Tech

(MarketWatch blog) June 18, 2013 - The market action is slow today, but one development is worth noting.
read article 

First Biopharm IPO in Three Years Proposed

(Philadelphia Business Journal) June 17, 2013 – Onconova Therapeutics Inc., a Bucks County biopharmaceutical company that is specializing in developing new cancer treatments, has filed plans for an initial public stock offering.
read article 

UK Weighs Price Cuts of Up to 20 Pct for Some Drugs

(Reuters) June 20, 2013 - Britain's Department of Health is aiming to cut some drug prices by between 10 and 20 percent as part of a drive to ensure the state healthcare system gets good value for money.
read article 

F.D.A. Clears Way for Contraceptive

(New York Times/Associated Press) June 20, 2013 - The Food and Drug Administration on Thursday approved unrestricted sales of Plan B One-Step, lifting all age limits on the emergency contraceptive.
read article 

Latest FDA Setback Sends Idenix Shares Tumbling After Hours

(NASDAQ/Dow Jones Newswires) June 20, 2013 - Idenix Pharmaceuticals Inc. said planned clinical trials for one of its experimental hepatitis C drugs have been put on hold after regulators requested additional safety data, dealing a blow to what analysts said is the company's most promising compound.
read article 

FDA Approves Abbott Test for Identifying Hepatitis C Genotypes

(Morningstar/Dow Jones Newswires) June 20, 2013 - The U.S. Food and Drug Administration has approved a test manufactured by Abbott Laboratories (ABT) that identifies the genotype of hepatitis C virus, or HCV, that a patient is carrying, helping health-care professionals determine the right type of treatment.
read article 

Novartis Heart Drug Gets FDA's 'Breakthrough' Status

(Fox News/Reuters) June 21, 2013 - Swiss pharmaceuticals company Novartis said on Friday U.S. regulators have given breakthrough therapy status to an investigational treatment for patients with acute heart failure, potentially fast tracking its development and approval.
read article 

Pharmacyclics Reports Results of Ibrutinib Phase II Study for Waldenstrom's Macroglobulinemia

(Drug June 21, 2013 - Clinical-stage biopharmaceutical company Pharmacyclics has announced results from Phase II study of oral Bruton's tyrosine kinase (BTK) inhibitor, Ibrutinib, conducted in patients with Waldenstrom's Macroglobulinemia (WM).
read article 

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Clinical Data at International Conference on Malignant Lymphoma

(Yahoo! Finance) June 21, 2013 - Seattle Genetics, Inc. today highlighted multiple ADCETRIS (brentuximab vedotin) data presentations at the 12th International Conference on Malignant Lymphoma (ICML) being held June 19-22, 2013 in Lugano, Switzerland.
read article 

Virus Combination Effective Against Deadly Brain Tumor, Moffitt Cancer Center Study Shows

(Moffitt Cancer Center) June 20, 2013 - A combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor, according to Moffitt Cancer Center research.
read press release 

QOPI® Spring Participation is Highest Ever

(ASCO in Action) June 20, 2013 - ASCO’s Quality Oncology Practice Initiative (QOPI®) recorded its highest level of participation ever in its spring collection round.
read article 

UT Dallas Study Suggests New Approach to Fighting Lung Cancer

(UT Dallas) June 20, 2013 - Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might provide a new strategy to combat lung cancer.
read press release 

Dr. Jame Abraham to Leave WVU

(WVU Healthcare) June 20, 2013 - Jame Abraham, M.D., medical director of the WVU Mary Babb Randolph Cancer Center and chief of the WVU Section of Hematology/Oncology in the WVU Department of Medicine, has resigned his post to become director of the Taussig Cancer Institute Breast Oncology Program and co-director of the Cleveland Clinic Multidisciplinary Breast Cancer Program.
read press release 

Multiple Myeloma Research Foundation (MMRF) Announces Janssen Research & Development, LLC Joins Innovative Pre-competitive Consortium to Advance Personalized Medicine Approaches for Multiple Myeloma

(MMRF) June 20, 2013 - The Multiple Myeloma Research Foundation (MMRF) today announced that Janssen Research & Development, LLC (Janssen R&D) has joined the MMRF pre-competitive consortium (PCC) to discover and accelerate new approaches to treating multiple myeloma through the organization’s Personalized Medicine Initiative (PMI).
read press release 

Pluripotent Stem Cells Made From Pancreatic Cancer Cells Are First Human Model of the Cancer's Progression, Penn Study Finds

(Penn Medicine) June 20, 2013 - Markers discovered in initial stages of disease could be used for early detection, treatment, prognosis.
read press release 

Lung Cancer Foundation's 360 Community Hospital Program Improving Individualized Standard of Care for Patients

(Sacramento Bee) June 20, 2013 - The Bonnie J. Addario Lung Cancer Foundation is creating a new patient-focused approach to standard of care for lung cancer with the launch of the Patient 360 Community Hospital Program.
read article 

Researchers Discover How A Mutated Protein Outwits Evolution And Fuels Leukemia

(NYU Langone) June 20, 2013 - Scientists have discovered the survival secret to a genetic mutation that stokes leukemia cells, solving an evolutionary riddle and paving the way to a highly targeted therapy for leukemia.
read press release 

Biodesix Secures Medicare Coverage for VeriStrat® Test

(Fort Mill Times) June 20, 2013 - Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that Novitas Solutions, the Medicare Administrative Contractor for the region that includes Colorado, has established coverage for the company’s VeriStrat test.
read article